Home Drug Pricing Why an Obscure Washington Firm Could Threaten Big Pharma?

Why an Obscure Washington Firm Could Threaten Big Pharma?

378
0
Drug Pricing

The Washington Examiner introduces readers to The Institute for Clinical Research and Economic Review (ICER), an obscure Washington DC firm that may worry some of the world’s biggest pharmaceutical companies. ICER evaluates prescription drugs to determine whether the list prices align with the clinical and economic value for patients. Follow the link below to read this interesting interview to learn more about this influential firm few have heard of.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.